Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics

Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics

US Patent 10738325 · Granted Aug 11, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oncolytic adenovirus with enhanced replication properties comprising modificatio2025
Oncolytic adenovirus with enhanced replication properties comprising modificatio2025
Exogenous gene expression in recombinant adenovirus for minimal impact on viral 2025
Exogenous gene expression in recombinant adenovirus for minimal impact on viral 2025
Exogenous gene expression in recombinant adenovirus for minimal impact on viral 2025
Tumor-targeting synthetic adenoviruses and uses thereof2023
Tumor-targeting synthetic adenoviruses and uses thereof2023
Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound2023
Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound2023
Exogenous gene expression in recombinant adenovirus for minimal impact on viral 2022
Exogenous gene expression in recombinant adenovirus for minimal impact on viral 2022
Exogenous gene expression in recombinant adenovirus for minimal impact on viral 2022